Cargando…
A New Trick of an Old Molecule: Androgen Receptor Splice Variants Taking the Stage?!
Prostate cancer is the second leading cause of cancer-related death in American men. Although most prostate cancers are initially androgen-dependent and respond to androgen ablation therapy, majority of them eventually relapse and progress into incurable castration-resistant (or hormone refractory)...
Autores principales: | Guo, Zhiyong, Qiu, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133889/ https://www.ncbi.nlm.nih.gov/pubmed/21750650 |
Ejemplares similares
-
The cyclin D1b splice variant: an old oncogene learns new tricks
por: Knudsen, Karen E
Publicado: (2006) -
Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016) -
CTCF as a regulator of alternative splicing: new tricks for an old player
por: Alharbi, Adel B, et al.
Publicado: (2021) -
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy
por: Cao, Bo, et al.
Publicado: (2014) -
Decoding the androgen receptor splice variants
por: Lu, Changxue, et al.
Publicado: (2013)